These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28606001)

  • 1. Heparin-induced thrombocytopenia (HIT).
    Evans NS; Gomes M
    Vasc Med; 2017 Aug; 22(4):353-355. PubMed ID: 28606001
    [No Abstract]   [Full Text] [Related]  

  • 2. Autoimmune heparin-induced thrombocytopenia.
    Greinacher A; Selleng K; Warkentin TE
    J Thromb Haemost; 2017 Nov; 15(11):2099-2114. PubMed ID: 28846826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refractory Heparin-Induced Thrombocytopenia With Cerebral Venous Sinus Thrombosis Treated With IVIg, Steroids, and a Combination of Anticoagulants: A Case Report.
    Gonzales M; Pipalia A; Weil A
    J Investig Med High Impact Case Rep; 2019; 7():2324709619832324. PubMed ID: 30939936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-induced thrombocytopenia (HIT II) - a drug-associated autoimmune disease.
    Nowak G
    Thromb Haemost; 2009 Nov; 102(5):887-91. PubMed ID: 19888524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential prevalence of anti-heparin-PF4 immunoglobulin subtypes in patients treated with clivarin and heparin: implications in the HIT pathogenesis.
    Ahmad S; Untch B; Haas S; Hoppensteadt DA; Misselwitz F; Messmore HL; Walenga JM; Fareed J
    Mol Cell Biochem; 2004 Mar; 258(1-2):163-70. PubMed ID: 15030181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-induced thrombocytopenia: a serious complication of heparin therapy for acute stroke.
    Kawano H; Toyoda K; Miyata S; Yamamoto H; Okamoto A; Kakutani I; Walenga JM; Naritomi H; Minematsu K
    Cerebrovasc Dis; 2008; 26(6):641-9. PubMed ID: 18984950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of an international survey of opinions on the definitions and treatments for heparin-induced thrombocytopenia: communication from the ISTH SSC Subcommittee on Platelet Immunology.
    Choi PY; Uzun G; Bakchoul T;
    J Thromb Haemost; 2024 Jun; 22(6):1772-1778. PubMed ID: 38301999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-induced thrombocytopenia in myeloproliferative disorders: a rare or under-diagnosed complication?
    Spectre G; Kalish Y; Schliamser L; Varon D
    Am J Hematol; 2008 May; 83(5):420-3. PubMed ID: 18181201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance characteristics of an automated latex immunoturbidimetric assay [HemosIL
    Warkentin TE; Sheppard JI; Linkins LA; Arnold DM; Nazy I
    Thromb Res; 2017 May; 153():108-117. PubMed ID: 28391124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin release assay (SRA)-negative HIT, a newly recognized entity: Implications for diagnosis and management.
    Pandya KA; Johnson EG; Davis GA; Padmanabhan A
    Thromb Res; 2018 Dec; 172():169-171. PubMed ID: 30419472
    [No Abstract]   [Full Text] [Related]  

  • 11. P-selectin and antibodies against heparin-platelet factor 4 in patients with venous or arterial diseases after a 7-day heparin treatment.
    Papalambros E; Sigala F; Travlou A; Bastounis E; Mirilas P
    J Am Coll Surg; 2004 Jul; 199(1):69-77. PubMed ID: 15217633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet count recovery and seroreversion in immune HIT despite continuation of heparin: further observations and literature review.
    Shih AW; Sheppard JI; Warkentin TE
    Thromb Haemost; 2017 Oct; 117(10):1868-1874. PubMed ID: 28837208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient pseudothrombocytopenia associated with immune heparin-induced thrombocytopenia complicated by pulmonary embolism.
    Zimrin AB; Warkentin TE
    Thromb Haemost; 2013 May; 109(5):971-3. PubMed ID: 23636478
    [No Abstract]   [Full Text] [Related]  

  • 14. Developing an algorithm for treating heparin-induced thrombocytopenia.
    McIntosh BA
    Clin Adv Hematol Oncol; 2004 Apr; 2(4):216-22. PubMed ID: 16163184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Diamed assay has a poor positive predictive value for HIT in a tertiary hospital referral setting.
    Alhaliq AR; Joshua D; Kershaw G; Dunkley S
    Int J Lab Hematol; 2007 Feb; 29(1):69-70. PubMed ID: 17224011
    [No Abstract]   [Full Text] [Related]  

  • 16. A modified PF4-dependent, CD62p expression assay selectively detects serotonin-releasing antibodies in patients suspected of HIT.
    Padmanabhan A; Jones CG; Bougie DW; Curtis BR; McFarland JG; Wang D; Aster RH
    Thromb Haemost; 2015 Nov; 114(6):1322-3. PubMed ID: 26177881
    [No Abstract]   [Full Text] [Related]  

  • 17. [Heparin-induced thrombocytopenia in hemodialysis. Case report and review of the literature].
    Henríquez F; Rodríguez A; Mora C; Sánchez-Deig E; Macía M; Navarro J
    Nefrologia; 2006; 26(6):734-7. PubMed ID: 17227252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia/thrombosis.
    Visentin GP; Moghaddam M; Beery SE; McFarland JG; Aster RH
    J Lab Clin Med; 2001 Jul; 138(1):22-31. PubMed ID: 11433225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Heparin-induced thrombocytopenia. New therapeutical options].
    Seculini Patiño CE; Tabares AH
    Medicina (B Aires); 2016; 76(4):230-4. PubMed ID: 27576282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Heparin-induced thrombocytopenia and thrombosis. Thrombosis as an early cardinal symptom of heparin allergy].
    Folwaczny EK; Stürmer KM
    Chirurg; 2002 Dec; 73(12):1197-203. PubMed ID: 12491049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.